LINC02422
gene geneOn this page
Summary
LINC02422 (long intergenic non-protein coding RNA 2422, HGNC:53352) is a long non-coding RNA gene on chromosome 12p11.21.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53352 |
| Approved symbol | LINC02422 |
| Name | long intergenic non-protein coding RNA 2422 |
| Location | 12p11.21 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000255760 |
| Ensembl biotype | lncRNA |
| Entrez | 105369723 |
| RNAcentral | URS0000A76CAC — lncRNA, 962 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000535163, ENST00000662662, ENST00000686104, ENST00000687652, ENST00000752257, ENST00000752258, ENST00000752259, ENST00000752260, ENST00000752261
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000535163 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004098170 | 31876966 | 31877893 |
| ENSE00004098172 | 31887167 | 31887218 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 84.32.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3269 / max 91.6264, expressed in 389 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 130399 | 0.6310 | 242 |
| 130395 | 0.3990 | 71 |
| 130398 | 0.2665 | 86 |
| 130396 | 0.0305 | 15 |
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| quadriceps femoris | UBERON:0001377 | 84.32 | gold quality |
| spleen | UBERON:0002106 | 80.32 | gold quality |
| lymph node | UBERON:0000029 | 77.89 | gold quality |
| cerebellar vermis | UBERON:0004720 | 77.73 | gold quality |
| blood | UBERON:0000178 | 75.22 | gold quality |
| monocyte | CL:0000576 | 75.08 | gold quality |
| leukocyte | CL:0000738 | 74.55 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.30 | silver quality |
| thymus | UBERON:0002370 | 73.39 | silver quality |
| vermiform appendix | UBERON:0001154 | 70.44 | gold quality |
| tonsil | UBERON:0002372 | 68.97 | gold quality |
| bone marrow cell | CL:0002092 | 68.23 | silver quality |
| granulocyte | CL:0000094 | 67.92 | gold quality |
| right uterine tube | UBERON:0001302 | 64.81 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 64.35 | gold quality |
| small intestine | UBERON:0002108 | 63.68 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.07 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 61.15 | gold quality |
| cortical plate | UBERON:0005343 | 61.00 | gold quality |
| fallopian tube | UBERON:0003889 | 60.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 60.20 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 60.16 | silver quality |
| bone marrow | UBERON:0002371 | 59.57 | gold quality |
| muscle tissue | UBERON:0002385 | 59.19 | gold quality |
| liver | UBERON:0002107 | 57.20 | gold quality |
| right lobe of liver | UBERON:0001114 | 57.13 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.67 | gold quality |
| rectum | UBERON:0001052 | 56.35 | gold quality |
| urinary bladder | UBERON:0001255 | 55.77 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.97 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.89 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.